# EDGAR Filing Document

**Accession Number:** 0001855447
**File Stem:** 0000000000-23-001991
**Filing Date:** 2023-2
**Character Count:** 15120
**Document Hash:** 4e6f659707bc6e972ef4bf080c66e3a6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-001991.hdr.sgml**: 20230524

**ACCESSION NUMBER**: 0000000000-23-001991

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230228

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Roth CH Acquisition IV Co.
- **CENTRAL INDEX KEY:** 0001855447
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 888 SAN CLEMENTE DRIVE SUITE 400
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92660
- **BUSINESS PHONE:** 9497205700

**MAIL ADDRESS:**
- **STREET 1:** 888 SAN CLEMENTE DRIVE SUITE 400
- **CITY:** NEWPORT BEACH
- **STATE:** CA
- **ZIP:** 92660
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001104659-22-131415

## Text-Extract

```

United States securities and exchange commission logo

                               February 28, 2023

       Gordon Roth
       Chief Financial Officer
       Roth CH Acquisition IV Co.
       888 San Clemente Drive, Suite 400
       Newport Beach, CA 92660

                                                        Re: Roth CH Acquisition
IV Co.
                                                            Amendment No. 1 to
Registration Statement on Form S-4
                                                            Filed February 14,
2023
                                                            File No. 333-269095

       Dear Gordon Roth:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our
January 27, 2023 letter.

       Form S-4/A filed February 14, 2023

       General

   1.                                                   We note your response
to prior comment one, but disagree that Tigo Energy, Inc. ("Tigo")
                                                        is not a "covered
person" under Rule 14e-5. Accordingly, please provide your analysis on
                                                        how the agreement for
Tigo to purchase common stock and private placement units would
                                                        comply with Rule 14e-5.
   2.                                                   With a view toward
disclosure, please tell us whether your sponsor is, is controlled by, or
                                                        has substantial ties
with a non-U.S. person. Please also tell us whether anyone or any
                                                        entity associated with
or otherwise involved in the transaction, is, is controlled by, or has
                                                        substantial ties with a
non-U.S. person. If so, also include risk factor disclosure that
                                                        addresses how this fact
could impact your ability to complete your initial business
 Gordon Roth
FirstName LastNameGordon
Roth CH Acquisition IV Co. Roth
Comapany28,
February  NameRoth
            2023     CH Acquisition IV Co.
February
Page 2 28, 2023 Page 2
FirstName LastName
         combination. For instance, discuss the risk to investors that you may
not be able to
         complete an initial business combination with a U.S. target company
should the
         transaction be subject to review by a U.S. government entity, such as
the Committee on
         Foreign Investment in the United States (CFIUS), or ultimately
prohibited. Further,
         disclose that the time necessary for government review of the
transaction or a decision to
         prohibit the transaction could prevent you from completing an initial
business
         combination and require you to liquidate. Disclose the consequences of
liquidation to
         investors, such as the losses of the investment opportunity in a
target company, any price
         appreciation in the combined company, and the warrants, which would
expire worthless.
3.       We note the use of the term "fully diluted" throughout the
registration statement, although
         the information presented does not reflect conversion of the
convertible note or exercise of
         certain warrants. Please revise the term appropriately, or
alternatively revise the
         information to reflect full dilution.
Risk Factors
There are risks to our public shareholders who are not affiliates of the
Sponsors..., page 71

4.       We note your response to prior comment 41 and re-issue it in part.
Please revise your risk
         factor disclosure to include a cross-reference to the discussion of
the various interests
         disclosed on pages 136-40, 220-22, and 288-92.
Management of ROCG
Executive Compensation, page 134

5.       We note your response to prior comment 33. Please further revise your
disclosure to
         include compensation information for your directors, in addition to
your executive
         officers.
ROCG Management's Discussion and Analysis of Financial Condition and Results of
Operations
Liquidity and Capital Resources, page 144

6.       The disclosure on page 144 appears to indicate that ROCG issued a
convertible note in an
         aggregate principal amount of $50 million on January 9, 2023; however,
the disclosure on
         page 248 states Tigo issued a convertible note in an aggregate
principal amount of $50
         million on January 9, 2023. Please revise your disclosure to address
this apparent
         discrepancy.
The Business Combination
Background of the Business Combination, page 200

7.       We note your response to prior comment 23 that the references to
forward purchase
         agreements (e.g., on pages 16 and 207) are to "transactions that would
constitute capital
         raise transactions under the merger agreement and not transactions
currently contemplated
         by ROCG." Please provide your analysis demonstrating how such
agreements comply
         with Rule 14e-5.
 Gordon Roth
Roth CH Acquisition IV Co.
February 28, 2023
Page 3
Sponsors' Prior SPAC Experience, page 214

8.       We note your response to prior comment 37. Please balance your
disclosure by including
         the redemption levels experienced by the other SPACs (in connection
with any extension
         request and/or the business combination) and by describing your
management's
         experience with SPACs that have not yet completed a business
combination.
Material U.S. Federal Income Tax Consequences, page 250

9.       We note your response to prior comment 42. Revised disclosure on page
254 appears to
         indicate that the opinion to be filed by counsel to Tigo will relate
to the tax consequences
         of the merger to holders of Tigo common stock. Please additionally
file an opinion
         regarding the tax consequences to public shareholders of exercising or
not exercising
         redemption rights.
Certain Relationships and Related Party Transactions
Related Party Loans, page 287

10.      Please update your disclosure to reflect the issuance of the $200,000
promissory note
         reported on the Form 8-K filed on February 14, 2023.
Financial Statements and Supplementary Data, page F-1

11.      Please include financial statements for the year ended December 31,
2022. Please
         similarly update your financial information throughout the filing. See
Rule 8-08 of
         Regulation S-X.
       You may contact Jeff Gordon at 202-551-3866 or Kevin Woody at
202-551-3629 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Alex King at 202-551-8631 or Jennifer Angelini at 202-551-3047 with any
other
questions.

FirstName LastNameGordon Roth                                  Sincerely,
Comapany NameRoth CH Acquisition IV Co.
                                                               Division of
Corporation Finance
February 28, 2023 Page 3                                       Office of
Manufacturing
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

February 28, 2023

Gordon Roth
Chief Financial Officer
Roth CH Acquisition IV Co.
888 San Clemente Drive, Suite 400
Newport Beach, CA 92660

**Re: Roth CH Acquisition IV Co.**
**Amendment No. 1 to Registration Statement on Form S-4**
**Filed February 14, 2023**
**File No. 333-269095**

Dear Gordon Roth:

We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our January 27, 2023 letter.

Form S-4/A filed February 14, 2023

General

1. We note your response to prior comment one, but disagree that Tigo Energy, Inc. ("Tigo") is not a "covered person" under Rule 14e-5. Accordingly, please provide your analysis on how the agreement for Tigo to purchase common stock and private placement units would comply with Rule 14e-5.
2. With a view toward disclosure, please tell us whether your sponsor is, is controlled by, or has substantial ties with a non-U.S. person. Please also tell us whether anyone or any entity associated with or otherwise involved in the transaction, is, is controlled by, or has substantial ties with a non-U.S. person. If so, also include risk factor disclosure that addresses how this fact could impact your ability to complete your initial business

Gordon Roth  
Roth CH Acquisition IV Co.  
February 28, 2023  
Page 2

combination. For instance, discuss the risk to investors that you may not be able to complete an initial business combination with a U.S. target company should the transaction be subject to review by a U.S. government entity, such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. Further, disclose that the time necessary for government review of the transaction or a decision to prohibit the transaction could prevent you from completing an initial business combination and require you to liquidate. Disclose the consequences of liquidation to investors, such as the losses of the investment opportunity in a target company, any price appreciation in the combined company, and the warrants, which would expire worthless.

3. We note the use of the term 'fully diluted' throughout the registration statement, although the information presented does not reflect conversion of the convertible note or exercise of certain warrants. Please revise the term appropriately, or alternatively revise the information to reflect full dilution.

#### Risk Factors

There are risks to our public shareholders who are not affiliates of the Sponsors..., page 71

4. We note your response to prior comment 41 and re-issue it in part. Please revise your risk factor disclosure to include a cross-reference to the discussion of the various interests disclosed on pages 136-40, 220-22, and 288-92.

#### Management of ROCG

Executive Compensation, page 134

5. We note your response to prior comment 33. Please further revise your disclosure to include compensation information for your directors, in addition to your executive officers.

#### ROCG Management's Discussion and Analysis of Financial Condition and Results of Operations Liquidity and Capital Resources, page 144

6. The disclosure on page 144 appears to indicate that ROCG issued a convertible note in an aggregate principal amount of $50 million on January 9, 2023; however, the disclosure on page 248 states Tigo issued a convertible note in an aggregate principal amount of $50 million on January 9, 2023. Please revise your disclosure to address this apparent discrepancy.

#### The Business Combination

Background of the Business Combination, page 200

7. We note your response to prior comment 23 that the references to forward purchase agreements (*e.g.*, on pages 16 and 207) are to 'transactions that would constitute capital raise transactions under the merger agreement and not transactions currently contemplated by ROCG.' Please provide your analysis demonstrating how such agreements comply with Rule 14e-5.

Gordon Roth  
Roth CH Acquisition IV Co.  
February 28, 2023  
Page 3

# Sponsors' Prior SPAC Experience, page 214

8. We note your response to prior comment 37. Please balance your disclosure by including the redemption levels experienced by the other SPACs (in connection with any extension request and/or the business combination) and by describing your management's experience with SPACs that have not yet completed a business combination.

# Material U.S. Federal Income Tax Consequences, page 250

9. We note your response to prior comment 42. Revised disclosure on page 254 appears to indicate that the opinion to be filed by counsel to Tigo will relate to the tax consequences of the merger to holders of Tigo common stock. Please additionally file an opinion regarding the tax consequences to public shareholders of exercising or not exercising redemption rights.

# Certain Relationships and Related Party Transactions

# Related Party Loans, page 287

10. Please update your disclosure to reflect the issuance of the $200,000 promissory note reported on the Form 8-K filed on February 14, 2023.

# Financial Statements and Supplementary Data, page F-1

11. Please include financial statements for the year ended December 31, 2022. Please similarly update your financial information throughout the filing. See Rule 8-08 of Regulation S-X.

You may contact Jeff Gordon at 202-551-3866 or Kevin Woody at 202-551-3629 if you have questions regarding comments on the financial statements and related matters. Please contact Alex King at 202-551-8631 or Jennifer Angelini at 202-551-3047 with any other questions.

Sincerely,

Division of Corporation Finance